Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
SINGAPORE, April 28, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or the “Company”), a Singapore-based clinical stage biopharmaceutical company focused on...
-
RTI to exhibit and speak at DeviceTalks Boston 2025
-
Vancouver, Canada, April 16, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and...
-
BOSTON, April 02, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics...
-
PEABODY, Mass., April 02, 2025 (GLOBE NEWSWIRE) -- Access, the world’s largest privately-held integrated information management services provider, has been named to the Boston Business Journal’s...
-
Webcast scheduled for Tuesday, April 1, 2025 at 8:00 AM ET. BOSTON, March 31, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused...
-
Austin, TX, USA, March 06, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “3D Cardiac Mapping System Market Size, Trends and Insights By Product Type...
-
EVast Bio pioneers the first human exosome therapy for knee osteoarthritis, showing promise in inflammation control and cartilage regeneration.
-
OPTIZMO returns as the Official Content Sponsor for LinkUnite V, celebrating women leaders, empowerment, innovation, and the event’s origins in Boston.
-
Austin, TX, USA, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Neurostimulation Device Market Size, Trends and Insights By Product (Spinal Cord...